Evaluation of lower urinary tract symptoms in patients with acromegaly: a study at the Centro Médico Nacional Siglo XXI, Mexico City
DOI:
https://doi.org/10.48193/23rj0j31Keywords:
acromegaly, growth hormone, lower urinary tract symptoms, obstructive prostatic growthAbstract
Objective: to determine if there is any relationship between acromegaly and the early development of lower urinary tract symptoms associated with serum levels of growth hormone.
Materials and methods: a cross-sectional, descriptive study was conducted with approval from the local research committee. Urodynamic variables were compared with normal or elevated levels of growth hormone to assess their relationship. Age, diabetes, hypertension, body mass index, IPSS, maximum urinary flow, residual urine, and growth hormone level were considered. Statistical analysis was performed using SPSS (version 25) with Mann-Whitney U test (p < 0.05).
Results: the study included 35 patients, with 19 men (54 %) and 16 women (46 %), with average ages of 57 and 54 years, respectively. The IPSS score was 8 (moderate) for men and 5 (mild) for women. The V/A index was 0.250 for men and 0.2 for women. The maximum urinary flow (QMAX) was 16.5 ml/s for men and 20.5 ml/s for women, while residual urine was 12.5 % for men and 8 % for women.
Conclusion: uncontrolled acromegaly showed a lower incidence of lower urinary tract symptoms and better measurements (IPSS, Qmax, residual urine).
References
1. Ogedegbe OJ, Cheema AY, Khan MA, Junaid SZS, Erebo JK, Ayirebi-Acquah E, et al. A Comprehensive Review of Four Clinical Practice Guidelines of Acromegaly. Cureus. 2022;14(9): e28722. https://doi.org/10.7759/cureus.28722.
2. Acevedo K, Aguilar-Pacheco PE, Arellano-Montaño S, Bastidas-Adrián MY, Domínguez B, García AR, et al. First report of the national acromegaly registry: The Epiacro Program. Revista de Endocrinología y Nutrición. 2010;18(4): 176–180.
3. Kumar S, Yadav RN, Gupta P, Gaspar BL, Kakkar N, Verma A, et al. Prostatic hyperplasia in acromegaly, a myth or reality: a case-control study. European Journal of Endocrinology. 2015;172(2): 97–106. https://doi.org/10.1530/EJE-14-0698.
4. ICS Glossary. Lower urinary tract symptom (LUTS). In: 2026.
5. Wei JT, Dauw CA, Brodsky CN. Lower Urinary Tract Symptoms in Men: A Review. JAMA. 2025;334(9): 809–821. https://doi.org/10.1001/jama.2025.7045.
6. EAU Guidelines. Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS). 2026.
7. Cambronero Santos J, Errando Smet C. Prevalence of storage lower urinary tract symptoms in male patients attending Spanish urology office. Urinary urgency as predictor of quality of life. Actas Urologicas Espanolas. 2016;40(10): 621–627. https://doi.org/10.1016/j.acuro.2016.04.012.
8. Carrero-López VM, Cózar-Olmo JM, Miñana-López B. Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence. Actas Urologicas Espanolas. 2016;40(5): 288–294. https://doi.org/10.1016/j.acuro.2015.12.008.
9. Chen YC, Chen HW, Chen MT, Huang CH, Li CC, Juan YS, et al. Severe prostate enlargement with severe lower urinary tract symptoms in poorly controlled acromegaly successfully treated with 5α-reductase inhibitors: A 15-year longitudinal case report. Lower Urinary Tract Symptoms. 2019;11(2): O218–O220. https://doi.org/10.1111/luts.12216.
10. Corrêa LL, Balarini Lima GA, Cavallieri SA, Miranda LCD de, Gadelha MR. Prostatic disorders in acromegalic patients experience of a Brazilian center. International Braz J Urol: Official Journal of the Brazilian Society of Urology. 2013;39(3): 393–401. https://doi.org/10.1590/S1677-5538.IBJU.2013.03.13.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Revista Mexicana de Urología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

